Concerns raised by hospital medical directors in a March letter warning about the “impending disintegration” of emergency ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

Northrop Grumman has received a $225.1 million contract modification from the U.S. Navy to develop and deliver training systems for the E-130J aircraft. As the Navy advances major modernization ...

WASHINGTON — Vietnam War veterans exposed to Agent Orange have a higher risk of developing a rare blood cancer that develops slowly over decades, according to a new study that for the first time links ...

In the first-line treatment of higher-risk myelodysplastic syndromes (MDS), the combination of venetoclax with azacitidine fell short of the primary endpoint of a reduction in mortality compared with ...

Lisaftoclax, a BCL-2 inhibitor, is being studied for first-line treatment of higher-risk myelodysplastic syndrome (HR-MDS) in a phase 3 trial. The trial, GLORA-4, combines lisaftoclax with azacitidine ...

The rise of e-bikes has brought an exciting new way to get around, but not without consequences. Huntington Beach had 147 reported e-bike crashes in 2024, more than double the amount reported two ...

The U.S. Navy’s Naval Air Warfare Center Training Systems Division is planning to award a contract potentially worth $401 million to Collins Aerospace, an RTX business, for the procurement of E-2D ...

Two abstracts presented at the 2024 American Society of Hematology Annual Meeting & Exhibition provided insight into MDS response to hypomethylating agents (HMAs). Patients with myelodysplastic ...